covid novavax - Search News

Order byBest matchMost fresh

Novavax scores narrower Covid vaccine approval

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's Covid-19 vaccine after more than a month of delay b

MPR · 5h

FDA’s New COVID-19 Vaccine Approval Policy May Limit Future Access

· 2d · on MSN

FDA approves Novavax COVID vaccine with new conditions

· 1h

Covid Vaccine Boosters Won’t Be Available for Healthy Adults Under 65. How Will That Work?

Covid-19 vaccines will no longer be available to everyone. Instead, annual boosters will be limited to people ages 65 and older, and those with certain medical conditions that put them at high risk f...

· 19h

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

· 1d

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved

· 5h

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

Public trust in vaccination has declined, potentially impacting other vital immunization programs.

· 1d

New federal rules for COVID boosters could delay shots for healthy adults, kids

· 1d

FDA sets new COVID booster guidelines for healthy adults under 65

7hon MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.

23hon MSN

FDA may limit future Covid-19 shots to older people and those at risk of serious infection

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 infection.

7hon MSN

FDA’s new approach raises questions about fall COVID vaccine availability

Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or whether they should be recommended only for people at increased risk.

20hon MSN

FDA sets new COVID booster guidelines for healthy adults under 65

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

Trump Administration Releases New COVID-19 Vaccine Plan: What to Know

In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well as children and younger adults who have one or more risk factors that make them more vulnerable to severe COVID-19.